Jaguar Health (JAGX) Accumulated Expenses (2014 - 2026)
Jaguar Health (JAGX) posted quarterly Accumulated Expenses of $4000.0 for Q1 2026, down 99.81% year-over-year from $2.1 million in Q1 2025, and down 98.88% quarter-over-quarter from $357000.0 in Q4 2025.
Jaguar Health (JAGX) Accumulated Expenses (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Accumulated Expenses for 13 consecutive years, with $4000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Accumulated Expenses fell 99.81% year-over-year to $4000.0; the TTM figure through Mar 2026 stood at $4000.0 (down 99.81% YoY), while the FY2025 annual figure was $357000.0, down 81.32% from the prior year.
- Accumulated Expenses fell to $4000.0 in Q1 2026 per JAGX's latest filing, from $357000.0 in the prior quarter.
- Across five years, Accumulated Expenses topped out at $10.0 million in Q2 2023 and bottomed at $4000.0 in Q1 2026.
- Historically, Accumulated Expenses has averaged $4.5 million across 5 years, with a median of $3.5 million in 2024.
- Annual changes were most pronounced in 2022 — Accumulated Expenses surged 1853.38% — and 2026, when it plunged 99.81%.
- Jaguar Health's Accumulated Expenses stood at $5.5 million in 2022, then tumbled by 96.21% to $208000.0 in 2023, then soared by 818.75% to $1.9 million in 2024, then tumbled by 81.32% to $357000.0 in 2025, then slumped by 98.88% to $4000.0 in 2026.
- Business Quant data shows JAGX's Accumulated Expenses at $4000.0 in Q1 2026, $357000.0 in Q4 2025, and $4.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Jaguar Health | 447,549.24 | -9.62 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,000.00 |
| Dec 31, 2025 | 357,000.00 |
| Sep 30, 2025 | 4.18 Mn |
| Jun 30, 2025 | 3.60 Mn |
| Mar 31, 2025 | 2.10 Mn |
| Dec 31, 2024 | 1.91 Mn |
| Sep 30, 2024 | 3.30 Mn |
| Jun 30, 2024 | 3.34 Mn |
| Mar 31, 2024 | 3.46 Mn |
| Dec 31, 2023 | 208,000.00 |
| Sep 30, 2023 | 3.29 Mn |
| Jun 30, 2023 | 10.02 Mn |
| Mar 31, 2023 | 9.28 Mn |
| Dec 31, 2022 | 5.49 Mn |
| Sep 30, 2022 | 8.50 Mn |
| Jun 30, 2022 | 8.91 Mn |
| Mar 31, 2022 | 8.20 Mn |
| Dec 31, 2021 | 281,000.00 |
| Sep 30, 2021 | 6.08 Mn |
| Jun 30, 2021 | 6.38 Mn |